S. Rajkumar, M. Dimopoulos, A. Palumbo, J. Bladé, G. Merlini, M. Mateos, Shaji K. Kumar, J. Hillengass, E. Kastritis, P. Richardson, O. Landgren, B. Paiva, A. Dispenzieri, B. Weiss, X. Leleu, S. Zweegman, S. Lonial, L. Rosiñol, E. Zamagni, S. Jagannath, O. Sezer, S. Kristinsson, J. Caers, S. Usmani, J. Lahuerta, H. Johnsen, M. Beksaç, M. Cavo, H. Goldschmidt, E. Terpos, R. Kyle, K. Anderson, B. Durie, J. Miguel
2014.11.1LANCET ONCOLOGY
tlooto Summary
The disease definition of multiple myeloma is updated to include validated biomarkers in addition to existing requirements of attributable CRAB features (hypercalcaemia, renal failure, anaemia, and bone lesions), and specific metrics that new biomarkers should meet for inclusion in the disease definition are provided.
Abstract
Abstract is not available.
Citation format
RAJKUMAR, S., et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. LANCET ONCOLOGY, 2014, 15 12: e538–48.